AlbertAugustusDavisMDPhD(He/Him)

PubMed

• 1 citations
  Frequency of Orthostatic Hypotension in Isolated REM Sleep Behavior Disorder.
  Elliott, J., Bryant-Ekstrand, M., Keil, A., Ligman, B., Lim, M., Zitser, J., During, E., Gagnon, J., St Louis, E., Fields, J., Huddleston, D., Bliwise, D., Avidan, A.,...> ;Neurology. 2023 Dec 12
• 12 citations
  An astrocyte BMAL1-BAG3 axis protects against alpha-synuclein and tau pathology.
  Patrick W Sheehan, Collin J Nadarajah, Michael F Kanan, Jessica N Patterson, Brenna Novotny, Jennifer H Lawrence, Melvin W King, Logan Brase, Casey E Inman, Carla M Yu...> ;Neuron. 2023 Aug 2
• 27 citations
  CSF tau microtubule-binding region identifies pathological changes in primary tauopathies.
  Kanta Horie, Nicolas R Barthélemy, Salvatore Spina, Lawren VandeVrede, Yingxin He, Ross W Paterson, Brenton A Wright, Gregory S Day, Albert A Davis, Celeste M Karch, W...> ;Nature Medicine. 2022 Dec 1
• 15 citations
  Neocortical Lewy Body Pathology Parallels Parkinson's Dementia, but Not Always.
  W R Wayne Martin, John R Younce, Meghan C Campbell, Brad A Racette, Scott A Norris, Mwiza Ushe, Susan Criswell, Albert A Davis, Isabel Alfradique-Dunham, Baijayanta Ma...> ;Annals of Neurology. 2023 Jan 1
• 71 citations
  Solving neurodegeneration: common mechanisms and strategies for new treatments.
  Lauren K Wareham, Shane A Liddelow, Sally Temple, Larry I Benowitz, Adriana Di Polo, Cheryl Wellington, Jeffrey L Goldberg, Zhigang He, Xin Duan, Guojun Bu, Albert A D...> ;Molecular Neurodegeneration. 2022 Mar 21
• 8 citations
  MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
  Chihiro Sato, Nipun Mallipeddi, Nupur Ghoshal, Brenton A Wright, Gregory S. Day, Albert A. Davis, Albert H. Kim, Gregory J. Zipfel, Randall J. Bateman, Audrey Gabelle,...> ;Annals of Clinical and Translational Neurology. 2021 Aug 2
• 23 citations
  Is Levodopa Response a Valid Indicator of Parkinson's Disease?
  W.R. Wayne Martin, Michael Miles, Qiaonan Zhong, Johanna M Hartlein, Brad A. Racette, Scott A. Norris, Mwiza Ushe, Baijayanta Maiti, Susan R. Criswell, Albert A. Davis...> ;Movement Disorders. 2021 Apr 1
• 6 citations
  Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease.
  Laura Ibanez, Jorge A. Bahena, Chengran Yang, Umber Dube, Fabiana H.G. Farias, John P. Budde, Kristy Bergmann, Carol Brenner-Webster, John C. Morris, Richard J. Perrin...> ;Acta Neuropathologica Communications. 2020 Nov 19
• 28 citations
  TDP-43 dysfunction results in R-loop accumulation and DNA replication defects.
  Matthew Wood, Annabel Quinet, Yea-Lih Lin, Albert A Davis, Philippe Pasero, Yuna M Ayala, Alessandro Vindigni> ;Journal of Cell Science. 2020 Oct 30
• Correction to: Overlapping genetic architecture between Parkinson disease and melanoma
  Umber Dube, Laura Ibanez, John P. Budde, Bruno A. Benitez, Albert A. Davis, Oscar Harari, Mark M. Iles, Matthew Law, Kevin M. Brown, Carlos Cruchaga> ;Acta Neuropathologica. 2020 Mar 14
• 91 citations
  APOE genotype regulates pathology and disease progression in synucleinopathy
  , , , , , , , , , , , , , , , > ;Science Translational Medicine. 2020 Feb 5
• 18 citations
  Overlapping genetic architecture between Parkinson disease and melanoma
  Umber Dube, Laura Ibanez, John P. Budde, Bruno A. Benitez, Albert A. Davis, Oscar Harari, Mark M. Iles, Matthew Law, Kevin M. Brown, Carlos Cruchaga> ;Acta Neuropathologica. 2020 Feb 1
• 3 citations
  A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson's Disease.
  John R. Younce, Albert A. Davis, Kevin J. Black> ;Journal of Parkinson's Disease. 2019 Jan 1
• 78 citations
  Intercellular Spread of Protein Aggregates in Neurodegenerative Disease.
  Albert A. Davis, Cheryl E. G. Leyns, David M. Holtzman> ;Annual Review of Cell and Developmental Biology. 2018 Oct 8
• 7 citations
  Cerebrovascular Events After Continuous-Flow Left Ventricular Assist Devices.
  Pouya Tahsili-Fahadan, David Curfman, Albert A. Davis, Noushin Yahyavi-Firouz-Abadi, Lucia Rivera-Lara, Michael E. Nassif, Shane J. LaRue, Gregory A. Ewald, Allyson R....> ;Neurocritical Care. 2018 Oct 1
• 17 citations
  Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease
  Laura Ibanez, Umber Dube, Albert A. Davis, Maria Victoria Fernandez, John P. Budde, Breanna Cooper, Monica Diez-Fairen, Sara Ortega-Cubero, Pau Pastor, Joel S. Perlmut...> ;Frontiers in Neuroscience. 2018 Apr 10
• 47 citations
  Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels.
  Laura Ibanez, Umber Dube, Benjamin Saef, John P. Budde, Kathleen Black, Alexandra Medvedeva, Jorge L. Del-Aguila, Albert A. Davis, Joel S. Perlmutter, Oscar Harari, Br...> ;BMC Neurology. 2017 Nov 15
• 8 citations
  TMEM230 in Parkinson's disease.
  Laura Ibanez, Umber Dube, John P. Budde, Kathleen Black, Alexandra Medvedeva, Albert A. Davis, Joel S. Perlmutter, Bruno A. Benitez, Carlos Cruchaga> ;Neurobiology of Aging. 2017 Aug 1
• 126 citations
  Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins
  Tien-Phat V. Huynh, Albert A. Davis, Jason D. Ulrich, David M. Holtzman> ;Journal of Lipid Research. 2017 Feb 27
• 25 citations
  Parkinson disease and cognitive impairment: Five new things
  Albert A. Davis, Brad A. Racette> ;Neurology. Clinical Practice. 2016 Oct 1
• 48 citations
  Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson’s Disease
  Bruno A. Benitez, Albert A. Davis, Sheng Chih Jin, Laura Ibanez, Sara Ortega-Cubero, Pau Pastor, Jae-Young Choi, Breanna Cooper, Joel S. Perlmutter, Carlos Cruchaga> ;Molecular Neurodegeneration. 2016 Apr 19
• 78 citations
  Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression
  Albert A. Davis, Kristin M. Andruska, Bruno A. Benitez, Brad A. Racette, Joel S. Perlmutter, Carlos Cruchaga> ;Neurobiology of Aging. 2016 Jan 1
• 87 citations
  Novel Allosteric Agonists of M1 Muscarinic Acetylcholine Receptors Induce Brain Region-Specific Responses That Correspond with Behavioral Effects in Animal Models
  Gregory J. Digby, M. J. Noetzel, Michael Bubser, T. J. Utley, A. G. Walker, Nellie Byun, Evan P. Lebois, Zixiu Xiang, Douglas J. Sheffler, Hykeyung P. Cho, A. A. Davis...> ;The Journal of Neuroscience. 2012 Jun 20
• 22 citations
  Differential Effects of Allosteric M1 Muscarinic Acetylcholine Receptor Agonists on Receptor Activation, Arrestin 3 Recruitment, and Receptor Downregulation
  Albert A. Davis, Craig J. Heilman, Ashley E. Brady, Nicole R. Miller, Maya Fuerstenau-Sharp, Bonnie J. Hanson, Craig W. Lindsley, P. Jeffrey Conn, James J. Lah, Allan ...> ;ACS Chemical Neuroscience. 2010 Aug 18
• 100 citations
  Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo.
  Albert A. Davis, Jason J. Fritz, Jürgen Wess, James J. Lah, Allan I. Levey> ;The Journal of Neuroscience. 2010 Mar 24
• Join now to see all